Clopidogrel-induced hypersensitivity syndrome associated with febrile pancytopenia [2]

International Journal of Dermatology

Volumn 44, Issue 10, 2005, Pages 882-884

  Comert, Asuman ^a   Akgun, Serdar ^a   Civelek, Ali ^a   Kavala, Mukaddes ^a   Sarigül, Şükram ^a   Yildirim, Tekin ^a   Arsan, Sinan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ANTIHISTAMINIC AGENT; ASPARTATE AMINOTRANSFERASE; CLOPIDOGREL; CORTICOSTEROID; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; CREAM; DESQUAMATION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; ERYTHEMA; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; MALE; PANCYTOPENIA; PHYSICAL EXAMINATION; POSTOPERATIVE CARE; SKIN BIOPSY; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

ADMINISTRATION, ORAL; DRUG ERUPTIONS; ERYTHEMA; FEVER; HUMANS; MALE; MIDDLE AGED; PANCYTOPENIA; PLATELET AGGREGATION INHIBITORS; SKIN DISEASES; SYNDROME; TICLOPIDINE;

EID: 27544459742     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2005.02366b.x     Document Type: Letter

References (9)

1. Roujeau J-C, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272-1285.
2. Revuz J. New advances in severe drug reactions. Dermatol Clin 2001; 19: 697-709.
3. Neumann FJ, Kastrati A, Schuhlen H, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996; 334: 1084-1089.
4. Quinn MJ, Fitzgerald DJ. Ticlopidine and clopidogrel. Circulation 1999; 100: 1667-1672.
5. Yosipovitch G, Rechavia E, Feinmeser M, et al. Adverse cutaneous reactions to ticlopidine in patients with coronary stents. J Am Acad Dermatol 1999; 41: 473-476.
6. CAPRIE Steering Committee. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-1339.
7. El-Majjaoui S, Tournillac I, Panzani V, et al. Toxic skin reaction to clopidogrel. J Mal Vasc 2001; 26: 207-208.
8. Green D. CAPRIE trial. Lancet 1997; 349: 354-355.
9. Andres E, Perrin AE, Alt M, et al. Febrile pancytopenia associated with clopidogrel. Arch Intern Med 2001; 161: 125.